{
 "id": "eprb70v6ze",
 "slug": "lymphaticovenular-anastomosis",
 "title": "Lymphaticovenular anastomosis",
 "updated": "2026-10-25",
 "topic_path": [
  {
   "id": "life",
   "label": "Life and health",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life"
  },
  {
   "id": "life.health",
   "label": "Human health and medicine",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life.health"
  },
  {
   "id": "life.health.clinical",
   "label": "Clinical assessment and procedures",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical"
  },
  {
   "id": "life.health.clinical.clinical-surgery",
   "label": "Surgery and surgical specialties",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical.clinical-surgery"
  },
  {
   "id": "life.health.clinical.clinical-surgery.plastic-reconstructive-and-oncologic-surgery-pro",
   "label": "Plastic, reconstructive, and oncologic surgery procedures",
   "api_url": "https://www.edgepedia.org/api/v1/topics/life.health.clinical.clinical-surgery.plastic-reconstructive-and-oncologic-surgery-pro"
  }
 ],
 "geo": [
  {
   "id": "geo.nongeo.t1946.life.health.clinical.clinical-surgery.plastic-reconstructive-and-oncologic-surgery-pro",
   "label": "Non-geographic · 1946 to 2000: Plastic, reconstructive, and oncologic surgery procedures",
   "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-surgery.plastic-reconstructive-and-oncologic-surgery-pro",
   "path": [
    {
     "id": "geo.nongeo",
     "label": "Non-geographic",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo"
    },
    {
     "id": "geo.nongeo.t1946",
     "label": "Non-geographic · 1946 to 2000",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946"
    },
    {
     "id": "geo.nongeo.t1946.life",
     "label": "Life and health",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life"
    },
    {
     "id": "geo.nongeo.t1946.life.health",
     "label": "Human health and medicine",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health"
    },
    {
     "id": "geo.nongeo.t1946.life.health.clinical",
     "label": "Clinical assessment and procedures",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical"
    },
    {
     "id": "geo.nongeo.t1946.life.health.clinical.clinical-surgery",
     "label": "Surgery and surgical specialties",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-surgery"
    },
    {
     "id": "geo.nongeo.t1946.life.health.clinical.clinical-surgery.plastic-reconstructive-and-oncologic-surgery-pro",
     "label": "Plastic, reconstructive, and oncologic surgery procedures",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.nongeo.t1946.life.health.clinical.clinical-surgery.plastic-reconstructive-and-oncologic-surgery-pro"
    }
   ]
  }
 ],
 "excerpt": "Lymphaticovenular anastomosis (LVA) is a minimally invasive microsurgical operation connecting sub-1 mm lymphatic vessels to small veins so lymph drains into the bloodstream, a physiologic treatment for lymphedema.",
 "snippet": "Lymphaticovenular anastomosis (LVA) is a minimally invasive microsurgical operation connecting sub-1 mm lymphatic vessels to small veins so lymph drains into the bloodstream, a physiologic treatment for lymphedema.",
 "node": "life.health.clinical.clinical-surgery.plastic-reconstructive-and-oncologic-surgery-pro",
 "markdown": "# Lymphaticovenular anastomosis\n\nLymphaticovenular anastomosis (LVA) is a microsurgical operation that connects a lymphatic collecting vessel of a swollen limb to a small adjacent vein, typically under 1 mm in diameter, so that stagnant lymph drains directly into the venous system.<sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup> It is a physiologic treatment for lymphedema: rather than removing tissue, it creates a new path for lymph to bypass damaged or blocked drainage routes and re-enter the bloodstream.<sup>[2](https://www.sciencedirect.com/science/article/pii/S2949912724000965)</sup> The connections are made between functioning lymphatic vessels larger than 0.1 mm and under 0.8 mm in diameter and similarly sized subdermal venules.<sup>[3](https://rcastoragev2.blob.core.windows.net/8f8974d692e0dd3d4052438146cc78cb/PMC6899961.pdf)</sup> The procedure is minimally invasive, is performed through 3 to 5 cm incisions under local or general anesthesia, and is generally preferred as a lower-risk option compared with vascularized lymph node transfer, although no widely accepted consensus on its indications exists.<sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup><sup> • </sup><sup>[4](https://journals.lww.com/jcma/fulltext/2024/05000/supermicrosurgical_lymphovenous_anastomosis.2.aspx)</sup>\n\n| Key fact | Detail |\n|---|---|\n| Vessels connected | Lymphatics >0.1 to <0.8 mm to subdermal venules typically <1 mm<sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup><sup> • </sup><sup>[3](https://rcastoragev2.blob.core.windows.net/8f8974d692e0dd3d4052438146cc78cb/PMC6899961.pdf)</sup> |\n| Sutures | 11-0 or 12-0 nylon; 12-0 on a 50-µm needle is generally preferred, 11-0 for vessels 0.5 mm or larger<sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup><sup> • </sup><sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup> |\n| Anastomoses per limb | Mean 3.9 (range 1–9.3) across lower-extremity studies; typically 2–4<sup>[6](https://journals.lww.com/prsgo/fulltext/2022/10000/outcomes_of_lymphovenous_anastomosis_for_lower.4.aspx)</sup><sup> • </sup><sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup> |\n| Volume reduction | Average 22.67% of limb volume; 45.52% of excess volume<sup>[6](https://journals.lww.com/prsgo/fulltext/2022/10000/outcomes_of_lymphovenous_anastomosis_for_lower.4.aspx)</sup> |\n| Cellulitis reduction | Pooled mean −1.13 events/year (upper limb) and −1.32 events/year (lower limb)<sup>[7](https://pubmed.ncbi.nlm.nih.gov/41071856/)</sup> |\n| Compression therapy | Approximately 30% to 100% of patients discontinue it after LVA<sup>[4](https://journals.lww.com/jcma/fulltext/2024/05000/supermicrosurgical_lymphovenous_anastomosis.2.aspx)</sup> |\n| Best suited stage | ISL stage 1–2 lymphedema with patent lymphatic channels<sup>[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC5505824/)</sup> |\n\n## How it works\n\nThe operation establishes a shunt through which lymph enters the venous circulation under pressure from the lymphatic system. A connection between a functioning lymphatic vessel and a similarly sized subdermal venule allows unidirectional flow of lymph into the vein; subdermal venules are preferred because their lower pressure reduces the risk of venous backflow into the lymphatic channel.<sup>[3](https://rcastoragev2.blob.core.windows.net/8f8974d692e0dd3d4052438146cc78cb/PMC6899961.pdf)</sup> Surgeons take care to ensure lymph flows into the vein and never the reverse, and some prefer an end-to-side configuration specifically to reduce backflow risk.<sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup>\n\nWhen the lymphatic-to-venous pressure gradient is unfavorable, side-to-side or end-to-side configurations are chosen to take advantage of [Bernoulli's principle](https://www.edgepedia.org/bernoullis-principle); side-to-side anastomosis is the more technically demanding option and should be performed only when the involved vessels are 0.4 mm or more in diameter.<sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup> Configuration also affects drainage capacity: in the lymphaticovenular supermicrosurgical anastomosis configuration, one recipient vein can drain both antegrade and retrograde lymphatic flow, which is why this setup is considered the most efficient.<sup>[9](https://www.sciencedirect.com/science/article/pii/S174391912030546X)</sup>\n\n## How it is done\n\n**Preoperative mapping.** Candidates are selected at clinical ISL stage 1 or 2 after compliance with nonoperative measures.<sup>[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC5505824/)</sup> [Indocyanine green](https://www.edgepedia.org/indocyanine-green) (ICG) lymphography distinguishes \"linear\" patterns of functional lymphatics from \"dermal backflow\" patterns of stagnation; lymphoscintigraphy provides an objective but less detailed functional assessment.<sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup> For ICG mapping, 0.1–0.2 mL is injected intradermally with a 27-gauge needle over each webspace, and images are taken immediately after injection to avoid haze.<sup>[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC5505824/)</sup>\n\n**Incision and vessel identification.** Incisions are planned where ICG-mapped lymphatic vessels and infrared-mapped veins lie in close proximity, maximizing the number of anastomoses per incision.<sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup> Typical incision sites of roughly 3 to 5 cm include the dorsum of the distal forearm, the volar proximal forearm, the proximal arm, approximately 3 to 5 cm above the malleolus, the medial side about 5 cm below the knee, and the Superior-Edge-of-the-Knee Incision point along the great saphenous vein.<sup>[10](https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0042-1756348.pdf)</sup> Isosulfan blue is injected 2 cm distal to the skin markings just before each incision to enhance lymphatic identification, and dissection proceeds under 20–25× magnification in a caudo-cephalad direction.<sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup> Dissected lymphatics are graded as healthy, ectatic, contracted, or sclerotic; ectatic and contracted vessels can be used when necessary.<sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup>\n\n**Supermicrosurgical suturing.** Anastomoses are performed at 20–30× microscope magnification with 11-0 or 12-0 nylon.<sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup> One school prefers 12-0 nylon on a 50-µm needle, using 11-0 nylon for vessels 0.5 mm or larger, and may place a 7-0 monofilament nylon suture as an intravascular stent.<sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup> Another commonly described approach uses a shortened 11-0 nylon suture with typically 4 to 6 sutures per anastomosis.<sup>[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC5505824/)</sup>\n\n**Configurations and number.** Surgeons can choose end-to-end, side-to-end, end-to-side, or side-to-side anastomoses, with selection depending mainly on the size discrepancy between the lymphatic vessel and the recipient vein; for a larger venule with a smaller lymphatic, end-to-side, side-to-side, funnel, diamond, or venous branch-plasty techniques can be used, while side-to-end suits a small vein.<sup>[4](https://journals.lww.com/jcma/fulltext/2024/05000/supermicrosurgical_lymphovenous_anastomosis.2.aspx)</sup><sup> • </sup><sup>[11](https://www.jstage.jst.go.jp/article/jprs/advpub/0/advpub_2023-0017/_article/-char/en)</sup> The number performed varies widely: a mean of 3.9 per patient (range 1–9.3) across lower-extremity studies,<sup>[6](https://journals.lww.com/prsgo/fulltext/2022/10000/outcomes_of_lymphovenous_anastomosis_for_lower.4.aspx)</sup> and 8 to 15 per case in one high-volume practice, with endpoints of six hours of operative time, three consecutive negative incisions, or visible on-table limb decompression.<sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup>\n\n## Origin\n\nLymphovenous shunting was applied or studied for secondary extremity lymphedema during 1960 to 1970.<sup>[4](https://journals.lww.com/jcma/fulltext/2024/05000/supermicrosurgical_lymphovenous_anastomosis.2.aspx)</sup> An early experimental approach intercepted the saphenous vein and performed an end-to-end anastomosis with 4 to 6 evenly spaced interrupted sutures after cannulation and splinting of the lymphatic into the vein.<sup>[12](https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/pdf/v32n1p1_21.pdf)</sup> These early lymphovenous approaches gained little popularity; the field expanded after the introduction of supermicrosurgical anastomosis of lymphatic vessels with a diameter under 0.8 mm.<sup>[4](https://journals.lww.com/jcma/fulltext/2024/05000/supermicrosurgical_lymphovenous_anastomosis.2.aspx)</sup>\n\n## Variants\n\nSeveral named configurations extend the basic shunt. The all-star approach uses all four anastomosis types, end-to-end, end-to-side, side-to-end, and side-to-side, within a single surgical field to increase lymph flow diversion.<sup>[13](https://www.jprasurg.com/article/S1748-6815%2815%2900091-1/abstract)</sup> The double-barrel variant divides the recipient vein at its mid-point with an 11-0 nylon suture to create two lumens, each anastomosed to a corresponding lymphatic.<sup>[14](https://pmc.ncbi.nlm.nih.gov/articles/PMC9018996/)</sup> The overlapping end-to-end technique, tested in 17 patients, achieved a 100% success rate by clinical observation and intraoperative ICG lymphography.<sup>[15](https://link.springer.com/article/10.1186/s12893-024-02568-z)</sup>\n\n## Applications\n\nA meta-analysis of 1,281 subjects, mostly from pre-post studies, found an odds ratio of 0.07 (95% CI 0.04–0.13, p<0.001) favoring effective treatment of lymphedema.<sup>[16](https://journals.librarypublishing.arizona.edu/lymph/article/id/4670/)</sup> A systematic review of lower-extremity LVA covering 6,260 patients and 2,554 limbs found objective improvement rates from 23.3% to 100%, with an average limb volume reduction of 22.67% and an excess volume reduction of 45.52%.<sup>[6](https://journals.lww.com/prsgo/fulltext/2022/10000/outcomes_of_lymphovenous_anastomosis_for_lower.4.aspx)</sup> A meta-analysis of eight prospective studies (431 patients, mean follow-up 21.8 ± 7.7 months) found a mean limb volume reduction of 14.26% (95% CI 6.63–21.88) at one year, with 46.3% of patients reducing or discontinuing compression therapy.<sup>[17](https://link.springer.com/article/10.1007/s10549-025-07867-4)</sup> Across 23 studies of 648 limbs, LVA reduced annual cellulitis events by a pooled mean of 1.13 in upper and 1.32 in lower extremities.<sup>[7](https://pubmed.ncbi.nlm.nih.gov/41071856/)</sup> Reported outcomes are nonetheless inconsistent, likely related to surgical technique.<sup>[18](https://link.springer.com/chapter/10.1007/978-3-030-78028-9_34)</sup> Complications are rare: reported events include cellulitis, subcutaneous ecchymoses, lymphangitis, and failed anastomoses, with no major complications such as donor-site lymphedema.<sup>[6](https://journals.lww.com/prsgo/fulltext/2022/10000/outcomes_of_lymphovenous_anastomosis_for_lower.4.aspx)</sup> About 10% of stage 1–2 patients have no appropriate lymphatic channels, leading to abortion of the procedure; when no suitable duct is found, lymphatic tissue with multiple small channels can be intussuscepted (telescoped one vessel inside another) into the vein as a fallback.<sup>[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC5505824/)</sup> [Liposuction](https://www.edgepedia.org/liposuction) can be added when proximal lymphedema shows little improvement after distal LVA.<sup>[8](https://pmc.ncbi.nlm.nih.gov/articles/PMC5505824/)</sup>\n\n## Limitations and alternatives\n\nLVA addresses only the fluid component of lymphedema. Both LVA and lymph node-to-vein anastomosis are indicated only for fluid-predominant disease and do not effectively address the solid components of lymphedema-induced lipodystrophy or fibrosis, which should be ruled out clinically (non-pitting edema, no significant volume reduction after aggressive [complex decongestive therapy](https://www.edgepedia.org/complex-decongestive-therapy)) and radiologically with MRI.<sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup><sup> • </sup><sup>[19](https://www.mdpi.com/1718-7729/32/7/377)</sup> The ideal candidate has early or moderate breast cancer-related lymphedema (ISL stage I or II) with patent lymphatic channels; in advanced stage II–III disease, LVA alone has limited benefit and vascularized lymph node transfer or debulking may be needed.<sup>[1](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)</sup> In primary lymphedema with global lymphatic dysfunction on ICG lymphography, LVA may be a safer alternative to flap transfer because of donor-site lymphedema risk.<sup>[5](https://www.oaepublish.com/articles/2347-9264.2021.61)</sup>\n\nCompared with vascularized lymph node transfer in a meta-analysis of 648 limbs, LVA produced smaller cellulitis reductions (VLNT pooled mean differences −2.43 upper and −1.38 lower limbs) and VLNT reduced limb circumference by 42.7% in upper and 21.98% in lower extremities.<sup>[7](https://pubmed.ncbi.nlm.nih.gov/41071856/)</sup>\n\nRecent developments include robotic supermicrosurgery using the [Symani Surgical System](https://www.edgepedia.org/symani-surgical-system) with free-floating chopstick-like controllers and an 11-0 suture with an 80-micrometer needle,<sup>[19](https://www.mdpi.com/1718-7729/32/7/377)</sup> and immediate preventive LVA at the time of axillary lymph node dissection, where a systematic recipient vein selection protocol achieved technical execution success in 30 of 30 patients.<sup>[20](https://www.nature.com/articles/s41598-026-66536-8)</sup>\n\n## References\n\n1. [Lymphovenous anastomosis: microsurgical innovation and clinical outcomes in breast cancer-related lymphedema care (Frontiers in Surgery, 2025)](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1731257/full)\n2. [The evidence for the microsurgical management of lymphedema](https://www.sciencedirect.com/science/article/pii/S2949912724000965)\n3. [Efficacy and safety assessment of lymphovenous anastomosis in patients with primary and secondary lymphoedema: a systematic review of prospective evidence (PMC6899961)](https://rcastoragev2.blob.core.windows.net/8f8974d692e0dd3d4052438146cc78cb/PMC6899961.pdf)\n4. [Supermicrosurgical lymphovenous anastomosis (Journal of the Chinese Medical Association, 2024)](https://journals.lww.com/jcma/fulltext/2024/05000/supermicrosurgical_lymphovenous_anastomosis.2.aspx)\n5. [Supermicrosurgical lymphaticovenular anastomosis vs. vascularized lymph vessel transplant - technical optimization and when to perform which](https://www.oaepublish.com/articles/2347-9264.2021.61)\n6. [Outcomes of Lymphovenous Anastomosis for Lower Extremity Lymphedema: A Systematic Review (PRS Global Open)](https://journals.lww.com/prsgo/fulltext/2022/10000/outcomes_of_lymphovenous_anastomosis_for_lower.4.aspx)\n7. [Lymphovenous Anastomosis and Vascularized Lymph Node Transfer Reduce Long-term Cellulitis Events in Patients With Secondary Lymphedema: A Systematic Review and Meta-analysis](https://pubmed.ncbi.nlm.nih.gov/41071856/)\n8. [Lymphaticovenous Bypass: Adaptations and Lessons Learned (Plastic and Reconstructive Surgery Global Open)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5505824/)\n9. [Determining factors in relation to lymphovascular characteristics and anastomotic configuration in supermicrosurgical lymphaticovenular anastomosis – A retrospective cohort study](https://www.sciencedirect.com/science/article/pii/S174391912030546X)\n10. [Lymphaticovenular Anastomosis: Superficial](https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0042-1756348.pdf)\n11. [Fundamentals for Supermicrosurgical Lymphaticovenular Anastomosis: Part 1 Comprehensive Review of Anastomosis Techniques and Proposal for a Flowchart Algorithm (JPRS Japan)](https://www.jstage.jst.go.jp/article/jprs/advpub/0/advpub_2023-0017/_article/-char/en)\n12. [The studies on lymphatic venous anastomosis in lymphedema (Nagoya Journal of Medical Science)](https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/pdf/v32n1p1_21.pdf)\n13. [abstract (jprasurg.com)](https://www.jprasurg.com/article/S1748-6815%2815%2900091-1/abstract)\n14. [\"Double Barrel\" Lymphaticovenous Anastomosis: A Useful Addition to a Supermicrosurgeon's Repertoire](https://pmc.ncbi.nlm.nih.gov/articles/PMC9018996/)\n15. [The \"Overlapping\" Lymphaticovenous Anastomosis: an overlapped end-to-end anastomosis supermicrosurgical technique (BMC Surgery, 2024)](https://link.springer.com/article/10.1186/s12893-024-02568-z)\n16. [Lymphovenous Anastomosis for the Treatment of Lymphedema: A Systematic Review of the Literature and Meta-Analysis (Lymphology)](https://journals.librarypublishing.arizona.edu/lymph/article/id/4670/)\n17. [Lymphovenous bypass for the treatment of secondary lymphedema: A meta-analysis of prospective outcomes (Breast Cancer Research and Treatment)](https://link.springer.com/article/10.1007/s10549-025-07867-4)\n18. [Supermicrosurgical Lymphaticovenular Anastomosis (Springer chapter)](https://link.springer.com/chapter/10.1007/978-3-030-78028-9_34)\n19. [Robot-Assisted Lymph Node-to-Vein Anastomosis: Lessons from the First 22 Cases at a High-Volume Lymphatic Supermicrosurgery Center](https://www.mdpi.com/1718-7729/32/7/377)\n20. [Systematic recipient vein selection for immediate preventive lymphaticovenous anastomosis during axillary lymph node dissection (Scientific Reports)](https://www.nature.com/articles/s41598-026-66536-8)\n\n---\n*Topic: Encyclopedia › Life and health › Human health and medicine › Clinical assessment and procedures › Surgery and surgical specialties › Plastic, reconstructive, and oncologic surgery procedures*\n\n*Initially written Sep 29, 2026 · Edited: Oct 15, 2026; Oct 21, 2026; Oct 25, 2026*\n\n*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*\n\nLicense: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license\n",
 "same_as": [],
 "url": "https://www.edgepedia.org/lymphaticovenular-anastomosis",
 "markdown_url": "https://www.edgepedia.org/lymphaticovenular-anastomosis.md",
 "license": {
  "name": "Edgepedia Community License 1.0",
  "url": "https://www.edgepedia.org/edgepedia/license",
  "summary": "Free with credit, commercial use included. AI training is open to everyone. For other uses, organizations over USD 100M in revenue or 100M monthly users license separately.",
  "spdx": "LicenseRef-Edgepedia-Community-1.0"
 },
 "credit": "\"Lymphaticovenular anastomosis\", Edgepedia (EdgeChat), https://www.edgepedia.org/lymphaticovenular-anastomosis. Edgepedia Community License 1.0.",
 "credit_md": "\"[Lymphaticovenular anastomosis](https://www.edgepedia.org/lymphaticovenular-anastomosis)\", Edgepedia (EdgeChat), [https://www.edgepedia.org/lymphaticovenular-anastomosis](https://www.edgepedia.org/lymphaticovenular-anastomosis). [Edgepedia Community License 1.0](https://www.edgepedia.org/edgepedia/license).",
 "credit_html": "\"<a href=\"https://www.edgepedia.org/lymphaticovenular-anastomosis\">Lymphaticovenular anastomosis</a>\", Edgepedia (EdgeChat), <a href=\"https://www.edgepedia.org/lymphaticovenular-anastomosis\">https://www.edgepedia.org/lymphaticovenular-anastomosis</a>. <a href=\"https://www.edgepedia.org/edgepedia/license\">Edgepedia Community License 1.0</a>.",
 "speakable": "Lymphaticovenular anastomosis is a minimally invasive microsurgical operation connecting sub-1 mm lymphatic vessels to small veins so lymph drains into the bloodstream, a physiologic treatment for lymphedema."
}
